Integra (IART) - Net Sales Margin

Integra LifeSciences (IART) operates in a protected segment where demand for neurosurgery is independent of GDP growth rates. The company's revenues rely on a global network of hospitals and the division between tissue regeneration and neurosystems. Advanced wound coverings are driving current growth. The integral net margin indicator demonstrates the effectiveness of this strategy, with the metric level standing at 0.80.
Financial and market metric breakdowns for Integra LifeSciences (IART)

Sales margin determines the share of net profit in total revenue, serving as a measure of efficiency in converting income into final capital. By analyzing the current sales margin level on GURU.Markets, an investor assesses the sustainability of the Integra LifeSciences (IART) business model, where high profitability is driven by the monetization of consumables for Codman systems within the neurosurgery and regenerative medicine segments.